Clinical Trial Update: Clinical Study of Trap (FAPI) 3 PET Imaging in Noninvasive Diagnosis of Malignant Tumors

View source ↗

Summary

A clinical trial update describes a study of the FAPI-3 PET imaging tracer for noninvasive diagnosis of malignant tumors. The trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• FAPI-3 PET tracer (Fibroblast Activation Protein Inhibitor-3 (FAPI-3))

Snippet

Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Conditions: Cancer | Status: NOT_YET_RECRUITING